Zentiva Group a.s.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zentiva Group a.s.
Zentiva Enters A New Phase With Saltofte As CEO
Zentiva has announced that Steffen Saltofte will become CEO of the privately-owned generics firm, replacing Nick Haggar who has led the company for over four years.
Multiple Agreements At Adalvo As Company Expects To File 30 DCPs This Year
Alvo group B2B unit Adalvo expects to file 30 decentralized procedures in Europe over the coming year as it expands its partnerships with Frontier Biopharma, Zentiva and Stada.
Generics And Biosimilars Industry Reshaped By Transformations
The latest Generics Bulletin Top 50 ranking of global generics and biosimilars companies sees a new name in the top five amid transformations for some of the leading off-patent players. Meanwhile, a number of mid-level firms shift position and newcomers climb into the bottom of the table.
Big Pharma Restructures Commercial Teams In India
More foreign pharma firms, this time Sanofi and GSK, are reorganizing sales and marketing efforts accompanied by layoffs in India. Scrip talks to experts about what’s driving the right-sizing and the wider trend.
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
- Solacium Pharma Creo Pharmaceuticals Ltd.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.